Technical Data
P9102-34C
Protein C Inhibitor (PCI)
Description:
Applications:
Suitable for use in Immunofluorescence and ELISA. Other applications not tested.

Recommended Dilution:
ELISA: 10ug/ml
Optimal dilutions to be determined by the researcher.

Hybridoma:
NSO cells with spleen cells frm BALB/c mouse

Storage and Stability:
Lyophilized powder may be stored at 4C for short-term only. Reconstitute to nominal volume by adding sterile 40-50% glycerol and store at -20C. Reconstituted product is stable for 12 months at -20C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer
TypeIsotypeCloneGrade
MabIgG1,k5F118Affinity Purified
SizeStorageShippingSourceHost
500ug4C (-20C Glycerol)Blue IceHumanMouse
Concentration:
~1mg/ml
Immunogen:
Human urinary PCI.
Purity:
Purified by Protein A affinity chromatography.
Form
Supplied as a lyophilized powder in PBS, pH 7.4, 0.02% sodium azide, 20mg/ml mannitol. Reconstitute with 0.5ml sterile ddH2O or 40-50% glycerol.
Specificity:
Recognizes intact human Protein C Inhibitor (PCI) and PCI-target enzyme complexes.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
1. Geiger M, Priglinger U, Griffin JH, Binder BR: Urinary Protein C Inhibitor. Glycosaminoglycans synthesized by the epithelial kidney cell line TCl-598 enhance ist interaction with urokinase. J Biol Chem 266: 11851-11857 (1991). 2. Ecke S, Geiger M, Resch I, Jerabek I, Stingl L, Maier M, Binder BR: Inhibition of tissue kallikrein by protein C inhibitor. J Biol Chem 267: 7048-7052 (1992). 3. Prendes MJ, Bielek E, Zechmeister-Machhart M, Vanyek-Zavadil E, Carroll VA, Breuss J, Binder BR, Geiger M: Synthesis and ultrastructural localization of protein C inhibitor in human platelets and megakaryocytes. Blood 94: 1300-1312 (1999).